Institutes

Clinical neuroimmunology

team-item

Group leader

Roberto Furlan

MORE
Neuroimmunology is currently at the crossroad between neuroinflammation and neurodegeneration. The challenge posed by neurodegenerative disorders and their treatment, as well as the development of regenerative medicine in neuroscience cannot ignore the crucial interaction with the immune system. Thus, it is easy to forecast a rapid expansion of research in neuroimmunology to neurodegenerative and also psychiatric disorders. 

Research activity

The Clinical Neuroimmunology Unit has currently four main lines of research: a) investigation of basic immunological mechanisms underlying neuroinflammatory disorders, especially focused on myeloid cells; b) development of advanced therapies of neuroinflammatory disorders using biologicals like gene therapy or extracellular vesicles; c) development of body fluid biomarkers of CNS damage; d) neuroimmunology of psychiatric disorders with a special focus on mood disorders.

Click here to view our publications